BMY

Bristol-Myers
NYSE

Real-time Quotes | Nasdaq Last Sale

59.27
-0.13
-0.22%
After Hours: 59.02 -0.25 -0.42% 19:08 09/18 EDT
OPEN
59.09
PREV CLOSE
59.40
HIGH
59.72
LOW
58.83
VOLUME
13.94M
TURNOVER
--
52 WEEK HIGH
68.34
52 WEEK LOW
45.76
MARKET CAP
133.59B
P/E (TTM)
-573.7657
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile

Analyst Price Target

The average BMY stock price target is 73.25 with a high estimate of 85.00 and a low estimate of 64.00.

Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About BMY
Bristol-Myers Squibb Company is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products. The Company's pharmaceutical products include chemically synthesized drugs, or small molecules, and products produced from biological processes called biologics. Small molecule drugs are administered orally in the form of a pill or tablet. Biologics are administered to patients through injections or by infusion. The Company's products include Empliciti, Opdivo, Sprycel, Yervoy, Eliquis, Orencia, Baraclude, Hepatitis C Franchise, Reyataz Franchise and Sustiva Franchise. It offers products for a range of therapeutic classes, which include virology, including human immunodeficiency virus (HIV) infection; oncology; immunoscience, and cardiovascular. Its products are sold to wholesalers, retail pharmacies, hospitals, government entities and the medical profession across the world. The Company’s subsidiary is Celgene Corp.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Bristol-Myers Squibb Co stock information, including NYSE:BMY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BMY stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading BMY stock methods without spending real money on the virtual paper trading platform.